Development of a Survey to Assess the Acceptability of an Innovative Contraception Practice among Rural Pharmacists

Abstract

Improved access to effective contraceptive methods is needed in Canada, particularly in rural areas, where unintended pregnancy rates are high and specific sexual health services may be further away. A rural pharmacist may be the most accessible health care professional. Pharmacy practice increasingly incorporates cognitive services. In Canada many provinces allow pharmacists to independently prescribe for some indications, but not for hormonal contraception. To assess the acceptability for the implementation of this innovative practice in Canada, we developed and piloted a survey instrument. We chose questions to address the components for adoption and change described in Rogers' "diffusion of innovations" theory. The proposed instrument was iteratively reviewed by 12 experts, then focus group tested among eight pharmacists or students to improve the instrument for face validity, readability, consistency and relevancy to community pharmacists in the Canadian context. We then pilot tested the survey among urban and rural pharmacies. 4% of urban and 35% of rural pharmacies returned pilot surveys. Internal consistency on repeated re-phrased questions was high (Cronbach's Alpha = 0.901). We present our process for the development of a survey instrument to assess the acceptability and feasibility OPEN ACCESSPharmacy 2014, 2 125 among Canadian community pharmacists for the innovative practice of the independent prescribing of hormonal contraception.

Provision of Sexual and Reproductive Health Services in Community Pharmacies: A Cross-Sectional Assessment of Structures and Processes in Jos, Nigeria

“…Community pharmacies have potential for expansion of SRH services as revealed in this study. This advantage can be exploited when we consider the fact that studies have shown that community pharmacies are well suited for expanding access to SRH services due to their extensive geographical spread among the populace and their extended opening hours [9,18]. However, this study identified inherent weaknesses in the structures and proces involve in the provision of SRH.…”

“…Thus, pharmacies are providing expanded access to family planning especially for unmarried and younger women [6,7]. In developed countries like the United States of America and Canada, many contraceptive products including the hormonal agent levonorgestrel are approved for OTC emergency dispensing, requiring a pharmacist's prescription for insurance reimbursements [8,9]. Similarly, in the United Kingdom community pharmacists evaluate clients and supervise the sale of emergency contraceptive products [10].…”

The acceptability of contraception task-sharing among pharmacists in Canada — the ACT-Pharm study

“…The questionnaire and the interview script both addressed all conceptual constructs for successful integration of an innovation into practice, as framed within Roger's theory of Diffusion of Innovations [21,22]. We have described the development, review, iterative pilot testing and validation of the survey [20]. Ethics approval was obtained from the University of BC, Children's and Women's Research Ethics Board (H12-01569).…”

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers

“…Based on the conceptual frameworks above and previous work [34,35], in October 2015, 4 of our clinicianresearchers who are experts in abortion care (group I: RR, WVN, SD, EG) created a survey instrument with 47 baseline questions and 21 follow-up questions. The questions were developed to assess facilitators and barriers to the adoption of mifepristone into practice as well as the impact of mandatory training on the practice of mifepristone medical abortion.…”

“…The Légaré instrument questions applied to a range of content areas; therefore, very few wording changes were required (see Table 3). Appropriate questions stemmed from 3 previously developed and fielded instruments developed by CART for the diffusion of contraception practice innovations [34,35,46] with minor modifications (e.g., "mifepristone" replacing "contraceptive" where appropriate).…”